These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 23316695)
1. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Vijayakumar MR; Muthu MS; Singh S Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695 [TBL] [Abstract][Full Text] [Related]
2. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells. Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701 [TBL] [Abstract][Full Text] [Related]
3. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Gan CW; Feng SS Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685 [TBL] [Abstract][Full Text] [Related]
4. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651 [TBL] [Abstract][Full Text] [Related]
5. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
6. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Zhang Z; Feng SS Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Lee SH; Zhang Z; Feng SS Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886 [TBL] [Abstract][Full Text] [Related]
8. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Tan YF; Chandrasekharan P; Maity D; Yong CX; Chuang KH; Zhao Y; Wang S; Ding J; Feng SS Biomaterials; 2011 Apr; 32(11):2969-78. PubMed ID: 21257200 [TBL] [Abstract][Full Text] [Related]
9. Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel. Xiong XY; Pan X; Tao L; Cheng F; Li ZL; Gong YC; Li YP Int J Biol Macromol; 2017 Oct; 103():1011-1018. PubMed ID: 28552723 [TBL] [Abstract][Full Text] [Related]
10. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302 [TBL] [Abstract][Full Text] [Related]
11. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758 [TBL] [Abstract][Full Text] [Related]
12. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles. Metin E; Mutlu P; Gündüz U Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763 [TBL] [Abstract][Full Text] [Related]
14. Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment. de Melo-Diogo D; Gaspar VM; Costa EC; Moreira AF; Oppolzer D; Gallardo E; Correia IJ Eur J Pharm Biopharm; 2014 Nov; 88(3):718-29. PubMed ID: 25308930 [TBL] [Abstract][Full Text] [Related]
16. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells. Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039 [TBL] [Abstract][Full Text] [Related]
17. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. Mi Y; Zhao J; Feng SS J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395 [TBL] [Abstract][Full Text] [Related]
18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
19. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
20. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]